niles blue A;Nilblau;C. I. Basic Blue 12;5-amino-9-diethylamino-benzo[a]phenoxazin-5-ylium;5-amino-9-diethylamino-benzo[a]phenoxazinylium;5-Amino-9-dimethylamino-benzophenoxazinium
NMR analysis of Nile Blue (C. I. Basic Blue 12) and Thionine (C. I. 52000) in solution
摘要:
The dyes Nile Blue (C I Basic Blue 12) and Thionine (C I 52000) were examined in both ionic and neutral forms in different solvents using NMR and UV-visible spectroscopy to firmly establish the structures of the molecules and to assess the nature and extent of their aggregation H-1 and C-13 NMR assignments and chemical shift data were used together with nuclear Overhauser effect information to propose a self-assembly structure These data were supplemented with variable temperature dilution and diffusion-based experimental results using H-1 NMR spectroscopy thereby enabling extended aggregate structures to be assessed in terms of the relative strength of self-association and the extent to which extended aggregates could form (C) 2010 Elsevier Ltd All rights reserved
DOI:
10.1016/j.dyepig.2010.07.014
作为产物:
描述:
在
Escherichia coli nitroreductase 、 还原型辅酶Ⅰ 作用下,
生成 nile blue
参考文献:
名称:
Activatable fluorogenic probe for accurate imaging of ulcerative colitis hypoxia in vivo
MEDICINAL COMPOSITION CONTAINING BENZO[A]PHENOXAZINE COMPOUND AS THE ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF PROTOZOAL DISEASE
申请人:Ihara Masataka
公开号:US20110021450A1
公开(公告)日:2011-01-27
Provided is a medicinal composition, in particular, a medicinal composition for treatment and/or prevention which has a high therapeutic effect on infection with a parasitic protozoa and a selective toxicity thereto and exhibits a life-prolonging effect and so on. A medicinal composition which contains as the active ingredient a benzo[a]phenoxazine compound represented by General formula (1) or a salt compound of the same, in particular, an agent for treating and/or preventing infection with a protozoa such as malaria, leishmaniasis, African trypanosomiasis, Chagas disease, toxoplasmosis, lymphatic filariasis, babesiosis or coccidium disease; and a novel compound which is contained therein as the active ingredient.
US8288374B2
申请人:——
公开号:US8288374B2
公开(公告)日:2012-10-16
Activatable fluorogenic probe for accurate imaging of ulcerative colitis hypoxia <i>in vivo</i>
作者:Mingrui Li、Yong Zhang、Xiaojun Ren、Wenchao Niu、Qing Yuan、Kai Cao、Jinchao Zhang、Xueyun Gao、Dongdong Su
DOI:10.1039/d1cc06577g
日期:——
An efficient probe NB-NO2 for specific imaging of ulcerative colitis via hypoxia detection was developed.